APIS Oncology Product Portfolio

Innovative Solutions for Oncology; Advanced Assays with Precise Results

NEW APIS ESR1 dPCR Kit

  • Wide target coverage: detects 11 ESR1 mutations

  • High sensitivity & specificity: detected at ≤ 0.1% MAF, with no WT detection

  • Instrument agnostic: compatible with most digital PCR systems

NEW APIS PIK3CA Mutations Kit

  • Streamlined workflow: detects > 95% of actionable PIK3CA mutations

  • High sensitivity: mutations detected at ≤ 0.5% MAF

  • Multiple sample types: FFPE tumour tissue or plasma (cfDNA)

APIS ESR1 Mutations Kit

  • Sensitive and precise qPCR assay detection of 11 ESR1 mutations within the oestrogen receptor gene

  • Utilises clamp and blocker technology, which ensures specific amplification, even in the presence of a high wild-type background

  • All mutations are detected at ≤ 1% MAF (Mutant Allele Frequency) ensuring high sensitivity

  • Our assays are designed to be user-friendly, with a simple protocol

APIS Breast Cancer Subtyping Kit

  • Novel RT-qPCR assay for detecting HER2, ER, PR & Ki67 mRNA expression with high precision and reproducibility

  • Single HER2 resolution method, without the need for reflex testing

  • Novel four-gene signature for measuring proliferation, supporting use of Ki67 alone

  • Automated results interpretation with APIS software

  • Opportunity to enhance HER2 stratification

APIS MET Alterations Kit

  • The new RT-qPCR assay for simultaneously detecting both MET exon 14 skipping mutation and MET gene overexpression

  • Simple protocol compatible with most qPCR cyclers

  • Designed for tumour tissue (FFPE) or liquid biopsy